Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02303392
Title Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jennifer Woyach
Age Groups: adult
Covered Countries USA

No variant requirements are available.